BRCA1 and breast carcinoma: Since we included high-risk clinical factors, the mutation frequency of BRCA1 in our cohort was 9.8% (113/1151), which was more than in unselected breast cancer populations, accounting for approximately 5%, according to the Cancer Genome Atlas [4, 5, 10].